Skip to content

BioFlo 44012Recalls & reported problems

Navilyst Medical, Inc. · BioFlo Plastic Port with Filled Suture Holes and 6F x 63cm Polyurethane Catheter with ENDEXO Technology · Class 2 · Implant

All models of BioFlo (87)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI H965440120), received between Dec 19, 2023 and Dec 19, 2023 — classified as 1 malfunction.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Implant Pain1
  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 19, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ANGIODYNAMICS RECEIVED A USER MEDWATCH (B)(4). A RISK MANAGER REPORTED AN ISSUE WITH A BIOFLO 6F SINGLE PLASTIC FILLED; NON-VALVED. THE FOLLOWING WAS REPORTED: "PATIENT IN CLINIC RECEIVING CHEMOTHERAPY. IMPLANTED PORT-A-CATH (PAC) LOWER RIGHT CHEST LATERAL TO ARMPIT ACCESSED WITH 20-GAUGE 3/4-INCH HUBER NEEDLE, SKIN INTACT; PORT ACCESSED PER PROTOCOL USING ASEPTIC TECHNIQUE, BRISK BLOOD RETURNED ACHIEVED AFTER 2ND RN ASSESSED PLACEMENT AND FLUSH PERFORMED WITHOUT DISCOMFORT, EASILY WITH BRISK BLOOD RETURN. PATIENT IS ABLE TO TASTE SALINE, NEEDLE SECURED WITH TEGADERM DRESSING. KVO FLUIDS INITIATED VIA PAC AND PRE-MEDS ADMINISTERED. PREMEDS GIVEN PER MAR. CHEMOTHERAPY ADMINISTERED SUBSEQUENTLY PER ORDERS; OXALIPLATIN AND LEUCOVORIN ADMINISTERED CONCURRENTLY PER PROTOCOL. PATIENT TOLERATED INFUSION WITHOUT ANY ADVERSE SIDE EFFECTS. POST OXALIPLATIN AND LEUKOVORIN, PATIENT NOTED THAT 'PORT' WAS 'HURTING'. PORT ASSESSED, NO VISIBLE SIGNS OF INFECTION, PORT FLUSHES EASILY, PATIENT ABLE TO TASTE/SMELL, NO BLOOD RETURN NOTED ON FLUSH. ON FURTHER REASSESSMENT AND REMOVAL OF TEGADERM, PATIENT STATES TENDERNESS ABOVE RIGHT BREAST WITHOUT REDNESS, STREAKING OR WARMTH. TREATMENT DISCONTINUED,

    Patient problems: Implant Pain; Pain

    MAUDE report 18357653 ↗

Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices

All PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page